Clinical Trials Directory

Trials / Unknown

UnknownNCT05034679

Impact of Corona Vaccination on AMH- Anti Mullerian Hormone

Wether Corona Vaccination Has Negative Impact on AMH- Anti Mullerian Hormone Which Express Ovarin Function

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Wolfson Medical Center · Other Government
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

Since December 2020 Nationwide anti-COVID-19 vaccination began in Israel using the Pfizer - BioNtech vaccine (BNT162b2 mRNA). The vaccination campaign has been associated with concerns regarding potential detrimental effects on future fertility. The aim of the study is to determine the impact of COVID-19 vaccination on n AMH- Anti Mullerian Hormone which express ovarin function. disease and/or immunization on human follicular function, by comparing follicular steroidogenesis, response to the LH/hCG trigger, and oocyte quality biomarker (HSPG2), in the aspirated follicular fluid of patients undergoing ovum pick-up.

Detailed description

Our assumption is that there is no effect of the vaccination on the AMH level. We plan to recruit 90 patients who are divided to three groups First group patients who vaccinated and measure the AMH before and up to 9 months after vaccination. Second group patients who were infected by Covid-19 ant therefor were not vaccinated to compare the AMH level before and after the infectious. The third group patients who were not infected and not vaccinated.

Conditions

Interventions

TypeNameDescription
BIOLOGICALVcinatedPatients who were vacinated.

Timeline

Start date
2021-07-15
Primary completion
2022-08-15
Completion
2022-10-15
First posted
2021-09-05
Last updated
2021-09-05

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT05034679. Inclusion in this directory is not an endorsement.